Analyst Ratings January 29, 2026

KeyBanc Lifts Meta Price Target to $855, Citing AI-Driven Productivity Gains

Analyst keeps Overweight rating as revenue momentum and infrastructure plans support a bullish revenue outlook

By Sofia Navarro META
KeyBanc Lifts Meta Price Target to $855, Citing AI-Driven Productivity Gains
META

KeyBanc Capital Markets increased its price target on Meta Platforms Inc. to $855 from $835 while retaining an Overweight recommendation. The upgrade follows what the firm described as a "blue-sky scenario" in Meta's fourth-quarter results, with the bank highlighting agentic coding-driven productivity gains, robust revenue growth, and infrastructure expansion that together underpin expectations for more than $90 billion in additional revenue between 2025 and 2027.

Key Points

  • KeyBanc raised its price target on Meta to $855 from $835 and retained an Overweight rating.
  • Meta trades at $668.73 with a $1.69 trillion market cap, an 82.01% gross profit margin, and 21.27% revenue growth over the past year.
  • Multiple brokerages raised or maintained Buy ratings, with price targets clustering between $820 and $940, reflecting positive sentiment across technology and advertising sectors.

KeyBanc Capital Markets has raised its target price for Meta Platforms Inc. to $855 from $835 and continues to carry an Overweight rating on the shares. The firm pointed to the company's fourth-quarter results and accompanying metrics as the basis for the move.

Meta is trading at $668.73 and has a market capitalization of $1.69 trillion. The company reports a gross profit margin of 82.01% and achieved 21.27% revenue growth over the last twelve months. These figures figure prominently in KeyBanc's reassessment of Meta's medium-term earnings trajectory.

KeyBanc characterized the fourth-quarter snapshot as a "blue-sky scenario," noting that although operating expenses and capital expenditures increased, the company offset those costs with a favorable revenue growth outlook and multiple indicators of value being delivered from artificial intelligence initiatives. The firm specifically pointed to agentic coding as a driver of material improvements in engineering productivity at the social media giant.

Beyond productivity, KeyBanc cited infrastructure growth as a complementary force. The analyst firm now expects Meta to add in excess of $90 billion of revenue during the 2025-2027 period, and it said concerns around return on investment have eased in light of the company’s recent disclosures and internal metrics.

The newly set $855 price target corresponds to a multiple of 25 times KeyBanc's estimated 2027 price-to-earnings for Meta. By comparison, the company currently trades at a P/E ratio of 29.65 and posts a PEG ratio of 4.21, which the firm notes implies Meta is trading at a premium relative to near-term earnings growth.

Independent valuation models show a range of analyst targets for the stock. Those targets run from $685 at the low end to $1,117 at the high end, and one comprehensive fair-value assessment indicated the shares are fairly valued under that model.

Other brokerages and research houses have also updated their views following Meta’s most recent results. Loop Capital reiterated a Buy rating with a $940 target. Stifel described results as "very healthy," raised its price objective to $820 and kept a Buy stance, pointing out that revenue exceeded the high end of guidance. Evercore ISI increased its target to $900 and cited about a 25% potential upside based on its earnings outlook. Canaccord Genuity adjusted its target to $930 after noting that Meta’s revenue and operating income beat consensus by roughly 3%, with advertising revenue up 23% year over year on a foreign-exchange-neutral basis. DA Davidson raised its target to $850 while maintaining a Buy rating.

Taken together, these analyst actions reflect a broadly positive tone among sell-side firms regarding Meta’s near-term results and medium-term prospects, driven by revenue momentum, AI-related productivity gains, and continued infrastructure investment.


Key points

  • KeyBanc raised Meta's price target to $855 from $835 and kept an Overweight rating, citing Q4 results and AI-driven productivity gains.
  • Meta is trading at $668.73 with a $1.69 trillion market cap, 82.01% gross profit margin, and 21.27% revenue growth over the past year.
  • Several brokerages raised or maintained Buy ratings with price targets ranging from $820 to $940, reflecting broadly positive analyst sentiment across the tech and advertising sectors.

Risks and uncertainties

  • Higher operating expenses and capital expenditures - These cost increases were highlighted in the fourth-quarter results and remain a factor for profitability and cash deployment.
  • Valuation premium - Meta currently trades at a P/E of 29.65 and a PEG of 4.21, indicating the shares are priced with premium expectations for near-term earnings growth.
  • Dependence on AI and infrastructure outcomes - The anticipated revenue additions and improved returns on investment rely on the realization of AI productivity gains and successful infrastructure expansion.

Risks

  • Rising operating expenses and capital expenditures could pressure profitability and returns - impacts corporate margins and technology infrastructure spending.
  • Current valuation metrics (P/E of 29.65 and PEG of 4.21) suggest the stock trades at a premium to near-term earnings growth - affects investors' expected returns in equity markets.
  • Revenue and return projections depend on AI-driven productivity gains and infrastructure deployment - outcomes could influence technology and digital advertising sectors.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026